Boothbay Fund Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Boothbay Fund Management’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-109,174	Closed	-$1.09M	–	2775
2022 Q3	$1.09M	Buy	109,174 +37,463	+52%	+$373K	0.03%	830
2022 Q2	$709K	Buy	71,711 +211	+0.3%	+$2.08K	0.02%	987
2022 Q1	$705K	Hold	71,500	–	–	0.02%	1114
2021 Q4	$701K	Hold	71,500	–	–	0.02%	891
2021 Q3	$701K	Buy	71,500 +21,500	+43%	+$212K	0.02%	929
2021 Q2	$495K	Buy	+50,000	New	+$503K	0.02%	1008

Boothbay Fund Management's LUXA Position: Q4 2022 in Review

Boothbay Fund Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 109,174 shares — an estimated $1.09M sold.

Boothbay Fund Management first reported a position in LUXA in Q2 2021 and held it in 6 quarters. The position peaked at $1.09M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Boothbay Fund Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Boothbay Fund Management sold 109,174 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $1.09M.
Boothbay Fund Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 6 quarters.
Boothbay Fund Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $1.09M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.